ASHM Report Back

Clinical posts from members and guests of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) from various international medical and scientific conferences on HIV, AIDS, viral hepatitis, and sexual health.

Zoster vaccine

  • Font size: Larger Smaller
  • Hits: 3588
  • Print

Herpes zoster is a common condition especially in our aging cohort.  There is limited information about the use of HZ vaccine in this group.  Paper 96 presented results from a randomised, double-blind, placebo-controlled trial assessing safety and immunogenicity of 2 doses of ZV in HIV+ adults ≥18 years old (CD4 >200 copies/µL; HIV RNA  Preliminary data suggest that the vaccine is generally safe, and immunogenic. Further data from this study is awaited.

 

 

 

Tagged in: CROI2012
  • No comments made yet. Be the first to submit a comment

Leave your comment

Guest
Guest Sunday, 23 September 2018

RT @qld_poz_people: MOSAIC, NAPWHA and Femfatales want to know about Women's experience of ageing with HIV. They have produced a survey whi…

ASHM ASHM